Mucosal-associated Invariant T-cell Activation and Accumulation After in Vivo Infection Depends on Microbial Riboflavin Synthesis and Co-stimulatory Signals
Overview
Authors
Affiliations
Despite recent breakthroughs in identifying mucosal-associated invariant T (MAIT) cell antigens (Ags), the precise requirements for in vivo MAIT cell responses to infection remain unclear. Using major histocompatibility complex-related protein 1 (MR1) tetramers, the MAIT cell response was investigated in a model of bacterial lung infection employing riboflavin gene-competent and -deficient bacteria. MAIT cells were rapidly enriched in the lungs of C57BL/6 mice infected with Salmonella Typhimurium, comprising up to 50% of αβ-T cells after 1 week. MAIT cell accumulation was MR1-dependent, required Ag derived from the microbial riboflavin synthesis pathway, and did not occur in response to synthetic Ag, unless accompanied by a Toll-like receptor agonist or by co-infection with riboflavin pathway-deficient S. Typhimurium. The MAIT cell response was associated with their long-term accumulation in the lungs, draining lymph nodes and spleen. Lung MAIT cells from infected mice displayed an activated/memory phenotype, and most expressed the transcription factor retinoic acid-related orphan receptor γt. T-bet expression increased following infection. The majority produced interleukin-17 while smaller subsets produced interferon-γ or tumor necrosis factor, detected directly ex vivo. Thus the activation and expansion of MAIT cells coupled with their pro-inflammatory cytokine production occurred in response to Ags derived from microbial riboflavin synthesis and was augmented by co-stimulatory signals.
Innateness transcriptome gradients characterize mouse T lymphocyte populations.
Ascui G, Cedillo-Castelan V, Mendis A, Phung E, Liu H, Verstichel G J Immunol. 2025; 214(2):223-237.
PMID: 40073243 PMC: 11878997. DOI: 10.1093/jimmun/vkae015.
Shin S, Kim H, Ko M, Park S, Park J, Kim S Front Microbiol. 2025; 16:1502630.
PMID: 40046304 PMC: 11880001. DOI: 10.3389/fmicb.2025.1502630.
Emgard J, Filipovic I, Unge C, Palma Medina L, Parke A, Bergsten H Clin Transl Immunology. 2025; 14(3):e70028.
PMID: 40041474 PMC: 11879382. DOI: 10.1002/cti2.70028.
Biological functions and therapeutic applications of human mucosal-associated invariant T cells.
Fang Y, Chen Y, Niu S, Lyu Z, Tian Y, Shen X J Biomed Sci. 2025; 32(1):32.
PMID: 40025566 PMC: 11871619. DOI: 10.1186/s12929-025-01125-x.
Sugimoto C, Wakao H Vaccines (Basel). 2025; 13(2).
PMID: 40006702 PMC: 11860804. DOI: 10.3390/vaccines13020155.